Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study
Author:
Alexander M Lesokhin,Joshua Richter,Suzanne Trudel,Adam D Cohen,Andrew Spencer,Peter A Forsberg,Jacob P Laubach,Sheeba K Thomas,Nizar J. Bahlis,Luciano J. Costa,Paula Rodriguez Otero,Maria-Victoria Mateos,Jesus G Berdeja,Rayan Kaedbey et al.
Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.